69 related articles for article (PubMed ID: 16030310)
1. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Iglesias-Serret D; Coll-Mulet L; Santidrián AF; Navarro-Sabaté A; Domingo A; Pons G; Gil J
J Natl Cancer Inst; 2005 Jul; 97(14):1090-1; author reply 1093-5. PubMed ID: 16030310
[No Abstract] [Full Text] [Related]
2. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Dicker F; Rauhut S; Kohlmann A; Kern W; Schoch C; Haferlach T; Schnittger S
J Natl Cancer Inst; 2005 Jul; 97(14):1092-3; author reply 1093-5. PubMed ID: 16030312
[No Abstract] [Full Text] [Related]
3. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Nenning UC; Eckert C; Wellmann S; Barth A; Henze G; Seeger K
J Natl Cancer Inst; 2005 Jul; 97(14):1091-2; author reply 1093-5. PubMed ID: 16030311
[No Abstract] [Full Text] [Related]
4. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Vargas RL; Felgar RE; Rothberg PG
J Natl Cancer Inst; 2005 Jul; 97(14):1089-90; author reply 1093-5. PubMed ID: 16030309
[No Abstract] [Full Text] [Related]
5. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Freeman SN; Bepler G; Haura E; Sutphen R; Cress WD
J Natl Cancer Inst; 2005 Jul; 97(14):1088-9; author reply 1093-5. PubMed ID: 16030308
[No Abstract] [Full Text] [Related]
6. The relevance of sequence insertions in the Mcl-1 promoter in chronic lymphocytic leukemia and in normal cells.
Coenen S; Pickering B; Potter KN; Johnson PW; Stevenson FK; Packham G
Haematologica; 2005 Sep; 90(9):1285-6. PubMed ID: 16154859
[TBL] [Abstract][Full Text] [Related]
7. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated.
Starczynski J; Pepper C; Pratt G; Hooper L; Thomas A; Milligan D; Bentley P; Fegan C
J Clin Oncol; 2005 Mar; 23(7):1514-21. PubMed ID: 15735127
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Moshynska O; Sankaran K; Pahwa P; Saxena A
J Natl Cancer Inst; 2004 May; 96(9):673-82. PubMed ID: 15126604
[TBL] [Abstract][Full Text] [Related]
9. Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or VH gene mutation status in chronic lymphocytic leukaemia.
Tobin G; Skogsberg A; Thunberg U; Laurell A; Aleskog A; Merup M; Sundström C; Roos G; Nilsson K; Rosenquist R
Leukemia; 2005 May; 19(5):871-3. PubMed ID: 15759030
[No Abstract] [Full Text] [Related]
10. Strong correlation between VEGF and MCL-1 mRNA expression levels in B-cell chronic lymphocytic leukemia.
Véronèse L; Tournilhac O; Verrelle P; Davi F; Dighiero G; Chautard E; Veyrat-Masson R; Kwiatkowski F; Goumy C; Gouas L; Bay JO; Vago P; Tchirkov A
Leuk Res; 2009 Dec; 33(12):1623-6. PubMed ID: 19487028
[TBL] [Abstract][Full Text] [Related]
11. MCL-1 promoter insertions dial-up aggressiveness of chronic leukemia.
Kitada S; Reed JC
J Natl Cancer Inst; 2004 May; 96(9):642-3. PubMed ID: 15126592
[No Abstract] [Full Text] [Related]
12. Low MCL-1 mRNA expression correlates with prolonged survival in B-cell chronic lymphocytic leukemia.
Véronèse L; Tournilhac O; Verrelle P; Davi F; Dighiero G; Chautard E; Veyrat-Masson R; Kwiatkowski F; Goumy C; Vago P; Travade P; Tchirkov A
Leukemia; 2008 Jun; 22(6):1291-3. PubMed ID: 18046444
[No Abstract] [Full Text] [Related]
13. Polymorphism in the CD5 gene promoter in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
Pérez-Chacón G; Contreras-Martín B; Cuní S; Rosado S; Martín-Donaire T; Losada-Fernández I; Vargas JA; Jordá J; Alvarez N; García-Marco J; Pérez-Aciego P
Am J Clin Pathol; 2005 May; 123(5):646-50. PubMed ID: 15981803
[TBL] [Abstract][Full Text] [Related]
14. Short nucleotide polymorphic insertions in the MCL-1 promoter affect gene expression.
Saxena A; Moshynska OV; Moshynskyy ID; Neuls ED; Qureshi T; Bosch M; Voralia M; Bonham K
Cancer Lett; 2007 Jun; 251(1):114-31. PubMed ID: 17198743
[TBL] [Abstract][Full Text] [Related]
15. G125A single-nucleotide polymorphism in the human BAX promoter affects gene expression.
Moshynska O; Moshynskyy I; Misra V; Saxena A
Oncogene; 2005 Mar; 24(12):2042-9. PubMed ID: 15688029
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of cell death of chronic lymphocytic leukemia lymphocytes by RNA-directed agent, 8-NH2-adenosine.
Balakrishnan K; Wierda WG; Keating MJ; Gandhi V
Clin Cancer Res; 2005 Sep; 11(18):6745-52. PubMed ID: 16166456
[TBL] [Abstract][Full Text] [Related]
17. Bax gene G(-248)A promoter polymorphism and chronic lymphocytic leukemia: lack of association with incidence, disease stage and progression-free survival.
Nückel H; Frey UH; Sellmann L; Bau M; Dürig J; Dührsen U; Siffert W
Leukemia; 2006 Apr; 20(4):724. PubMed ID: 16453002
[No Abstract] [Full Text] [Related]
18. Hypermethylation of the p15INK4B gene promoter in B-chronic lymphocytic leukemia.
Papageorgiou SG; Lambropoulos S; Pappa V; Economopoulou C; Kontsioti F; Papageorgiou E; Tsirigotis P; Dervenoulas J; Economopoulos T
Am J Hematol; 2007 Sep; 82(9):824-5. PubMed ID: 17546638
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia.
Bogunia-Kubik K; Mazur G; Urbanowicz I; Wróbel T; Kuliczkowski K; Woźniak M; Lange A
Int J Immunogenet; 2006 Feb; 33(1):21-4. PubMed ID: 16426238
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology of chronic lymphocytic leukemia: implications for therapy.
Reed JC
Semin Hematol; 1998 Jul; 35(3 Suppl 3):3-13. PubMed ID: 9685174
[No Abstract] [Full Text] [Related]
[Next] [New Search]
